BioRestorative Cash Per Share from 2010 to 2024

BRTX Stock  USD 1.50  0.03  1.96%   
BioRestorative Therapies Cash Per Share yearly trend continues to be fairly stable with very little volatility. Cash Per Share will likely drop to 2.49 in 2024. During the period from 2010 to 2024, BioRestorative Therapies Cash Per Share regression line of annual values had r-squared of  0.23 and arithmetic mean of  143.53. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
2.62370679
Current Value
2.49
Quarterly Volatility
240.09262368
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.4 M or Depreciation And Amortization of 177.8 K, as well as many indicators such as Price To Sales Ratio of 47.82, Dividend Yield of 0.0 or PTB Ratio of 0.77. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of BioRestorative Therapies over the last few years. It is BioRestorative Therapies' Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.92 X10 Years Trend
Slightly volatile
   Cash Per Share   
       Timeline  

BioRestorative Cash Per Share Regression Statistics

Arithmetic Mean143.53
Geometric Mean22.58
Coefficient Of Variation167.27
Mean Deviation175.25
Median17.70
Standard Deviation240.09
Sample Variance57,644
Range845
R-Value(0.48)
Mean Square Error47,677
R-Squared0.23
Significance0.07
Slope(25.86)
Total Sum of Squares807,023

BioRestorative Cash Per Share History

2024 2.49
2023 2.62
2022 4.08
2021 17.7
2020 7.76
2019 0.3
2018 40.08

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Cash Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Per Share 2.62  2.49 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.